Concise Prescribing Info Bahasa Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Side Effects Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Indications/Uses

GLYXAMBI (empagliflozin and linagliptin) is indicated for use in combination with metformin (≥1500 mg/day) as an adjunct to diet and exercise, to achieve glycemic control in adult patients with type 2 diabetes mellitus (T2DM): inadequately controlled on metformin (≥1500 mg/day) and empagliflozin, or inadequately controlled on metformin (≥1500 mg/day) and linagliptin.

Glyxambi Indications/Uses

Manufacturer:

Boehringer Ingelheim